Neuropeptides Receptors Changes in Huntington’s Chorea Basal Ganglia are Unrelated to Changes in Neuropeptides Levels

  • G. Chinaglia
  • F. J. Alvarez
  • A. Probst
  • J. M. Palacios
Part of the Advances in Behavioral Biology book series (ABBI, volume 39)


We have studied the distribution and densities of receptors for somatostatin, neurotensin and substance P in basal ganglia of patients affected by Huntington’s chorea using autoradiographic techniques. Somatostatin binding sites density appear to be decreased in neostriatum of these patients, probably because they are located on neurons sensitive to the disease process of Huntington’s chorea. Neurotensin and substance P receptors densities were found to be comparable to those of control cases suggesting that they are located on surviving neurons. Previous reports stated that in the same region the concentration of the peptide somatostatin is greatly increased, substance P is decreased and neurotensin is in the control range. Consequently, changes in receptors appear largely unrelated to alterations in transmitter levels. Our results suggest that receptors are expressed by cells which are different from those expressing the transmitter.


Basal Ganglion Nucleus Accumbens Receptor Density Insular Cortex Neurotensin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, E.D. Bird, and E.P. Richardson, Jr, Neuropathological classification of Huntington’s disease, J. Neuropathol. Exp. Neurol. 44: 559–577 (1985).PubMedCrossRefGoogle Scholar
  2. 2.
    G.A. Graveland, R.S. Williams, and M. Di Figlia, A Golgi study of the human neostriatum: Neurons and afferent fibers. J. Comp. Neurol. 234: 317–333 (1985).PubMedCrossRefGoogle Scholar
  3. 3.
    A. Reiner, R.L. Albin, K.D. Anderson, C.J. D’Amato, J.B. Penney, and A.B. Young, Differential loss of striatal projection neurons in Huntington disease, Proc. Natl. Acad. Sci. 85: 5733–5737 (1988).PubMedCrossRefGoogle Scholar
  4. 4.
    R.J. Ferrante, N.W. Kowall, M.F. Beal, J.B. Martin, E.D. Bird, and E.P. Richardson, Jr., Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington’s disease, J. Neuropathol. Exp. Neurol. 46: 12–27 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    R.J. Ferrante, M.F. Beal, N.W.Kowall, E.P. Richardson, Jr, and J.B. Martin, Sparing of acetylcolinesterasecontaining striatal neurons in Huntington’s disease, Brain Res. 411: 162–166 (1987).PubMedCrossRefGoogle Scholar
  6. 6.
    T.L. Perry, S. Hansen, and M. Kloster, Huntington’s chorea: Deficiency of T-aminobutyric acid in brain, N. Engl. J. Med. 288: 337–342 (1973).PubMedCrossRefGoogle Scholar
  7. 7.
    P.C. Emson, A. Arregui, V. Clement-Jones, B.E.B. Sandberg, M. Rossor,.Regional distribution of methionineenkephalin and substance P-like immunoreactivity in normal human brain and in Huntington’s disease, Brain Res. 199: 147–160 (1980).PubMedCrossRefGoogle Scholar
  8. 8.
    M.F. Beal, D.W. Ellison, M.F. Mazurek, K.J. Swartz, J. R. Malloy, E.D. Bird, and J.B. Martin, A detailed examination of substance F’ in pathologically graded cases of Huntington’s disease, J. Neurol. Sci. 84: 5161 (1988).Google Scholar
  9. 9.
    E.D. Bird, and L.L. Iversen, Huntington’s Chorea. Postmortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia, Brain, 97: 457–472 (1974).PubMedCrossRefGoogle Scholar
  10. 10.
    H. Bernheimer, and O. Hornykiewicz, Brain amines in Huntington’s chorea, Adv. Neurol. 1: 525–531 (1973).Google Scholar
  11. 11.
    N. Aronin, P.E. Cooper, L.J. Lorenz, E.D. Bird, S.M. Sagar, S.E. Leeman, and J.B. Martin, Somatostatin is increased in the basal ganglia in Huntington’s disease, Ann. Neurol., 13 (1983) 519–526.PubMedCrossRefGoogle Scholar
  12. 12.
    D. Dawbarn, M.E. De Quidt, and P.C. Emson, Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington’s Disease, Brain Research, 340: 251–260 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    J.B. Penney, Jr., and A.B.Young, Quantitative autoradiography of neurotransmitter receptors in Huntington’s disease, Neurology, 32: 1391–1395 (1982).PubMedCrossRefGoogle Scholar
  14. 14.
    P.J. Whitehouse, R. Trifiletti, B.E. Jones, S. Folstein, D.L. Price, S.H. Snyder, and M.J. Kuhar,Neurotransmitter receptor alterations in Huntington’s disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes, Ann. Neurol., 18: 202–210 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    C. Waeber and J.M. Palacios, Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington’s chorea but not in Parkinson’s disease: a quantitative in vitro autoradiography study, Neuroscience, 32: 337–347 (1989).PubMedCrossRefGoogle Scholar
  16. 16.
    J.C. Reubi, R. Cortés, R. Maurer, A. Probst and J.M. Palacios, Distribution of somatostatin receptors in the human brain: an autoradiographic study, Neuroscience, 18: 329–346 (1986).PubMedCrossRefGoogle Scholar
  17. 17.
    A. Sarrieau, F. Javoy-Agid, P. Kitabgi, M. Dussaillant, M. Vial, J.P. Vincent, Y. Agid and W.H. Rostène, Characterization and autoradiographic distribution of neurotensin binding sites in the human brain, Brain Res., 348: 375–380 (1985).PubMedCrossRefGoogle Scholar
  18. 18.
    J.C. Beaujouan, Y. Torrens, M. Saffroy and J. Glowinski, Quantitative autoradiographic analysis of the distribution of binding sites for [12I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain, Neuroscience, 18: 857–875 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    J.K. Ritter, D.R. Gehlert, J.W. Gibb, J.K. Wamsley, and G.R. Hanson, Neuronal localization of substance P receptors in rat neostriatum, Eur. J. Pharmacol., 109: 431–432 (1985).PubMedCrossRefGoogle Scholar
  20. 20.
    M. Goedert, K. Pittaway, and P.C. Emson, Neurotensin receptors in the rat striatum: lesion studies, Brain. Res., 299: 164–168 (1984).Google Scholar
  21. 21.
    J.C. Reubi, A. Probst, R. Cortés, and J.M. Palacios, Distinct topographical localization of two somatostatin receptor subpopulations in the human cortex, Brain Res., 406: 391–396 (1987).PubMedCrossRefGoogle Scholar
  22. 22.
    J.M. Palacios, A. Pazos, M.M. Dietl, M. Schlumpf and W. Lichtensteinger, The ontogeny of brain neurotensin receptors studied by autoradiography, Neuroscience, 25: 307–317.Google Scholar
  23. 23.
    M.M. Dietl, M. Sanchez, A. Probst and J.M. Palacios, Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis, Brain Res. 483, 39–49.Google Scholar
  24. 24.
    C.B.Srikant and Y.C. Patel, Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors, Endocrinol., 115: 990–995 (1984).CrossRefGoogle Scholar
  25. 25.
    G. Mengod and J.M. Palacios, Molecular neuropathology: the study of transmitter and receptor expression in human postmortem materials by in situ hybridization and receptor autoradiography, in: “Neuropsychopharmacology”, W.E. Bunney Jr, H. Hippius, G. Laakman and M. Schmauss, eds., Springer Verlag, Berlin (1990) in press.Google Scholar
  26. 26.
    M.F. Beal, N. W. Kowall, K.J. Swartz, R.J. Ferrante and J.B. Martin, Differential sparing of somatostatinneuropeptide Y and cholinergic neurons following striatal excitotoxin lesions, Synapse, 3: 38–47 (1989).PubMedCrossRefGoogle Scholar
  27. 27.
    Y. Torrens, J.C. Beaujouan, M. Saffroy, M.C. Daguet de Montety, L. Bergstrom and J. Glowinski, Substance P receptors in primary cultures of cortical astrocytes from the mouse, Proc. Natl. Acad. Sci. U.S.A., 83: 9216–9220 (1986).PubMedCrossRefGoogle Scholar
  28. 28.
    K.W. Eggerman and D.S. Zahm, Numbers of neurotensinimmunoreactive neurons selectively increased in rat ventral striatum following acute haloperidol administration, Neuropeptides, il: 125–132 (1988).Google Scholar
  29. 29.
    S. Govoni, J.S. Hong, H.Y.T. and E. Costa, Increase of neurotensin content elicited by neuroleptics in nucleus accumbens, J. Pharmacol. Exp. Therap., 215: 413–417 (1980).Google Scholar
  30. 30.
    C.B. Nemeroff, W. W. Youngblood, P.J. Manberg, A.J. Prange, Jr. and J.S. Kizer, Regional brain concentrations of neuropeptides in Huntington’s chorea and schizophrenia, Science 221: 972–975 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • G. Chinaglia
    • 1
  • F. J. Alvarez
    • 2
  • A. Probst
    • 1
  • J. M. Palacios
    • 2
  1. 1.Department of Pathology, Division of NeuropathologyUniversity of BaselBaselSwitzerland
  2. 2.Preclinical ResearchSandoz Pharma Ltd.BaselSwitzerland

Personalised recommendations